Author

Weidong Huang

Observed names: Huang, Weidong, W G Huang, W Huang, W. Huang, Wei-Dong Huang, Wei-dong Huang, Wei‐Dong Huang

Institution: Changchun University of Chinese Medicine

Observed institutions: Poznan University of Medical Sciences, Dartmouth–Hitchcock Medical Center, Pennsylvania State University, Mayo Clinic, Harbin Medical University, LabCorp (United States), Institut Jules Bordet, Xinhui People's Hospital, Lebanon VA Medical Center, Greater Poland Cancer Center, Lublin Oncology Center, Changchun University of Chinese Medicine, Chinese Academy of Forestry, Chengdu Second People's Hospital, Tennessee Oncology, Diazyme (United States), Mayo Clinic in Florida, Ministry of Agriculture and Rural Affairs, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Foundation Medicine (United States), Beijing Advanced Innovation Center for Food Nutrition and Human Health, China Agricultural University, Gdańsk Medical University, Medical University of Vienna, Penn State Milton S. Hershey Medical Center

ORCID: 0000-0003-2798-4735

Observed ORCID: 0000-0003-2798-4735

OpenAlex ID: A5083535676

Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients

2010 · Jeff Sperinde, Xueguang Jin, et al. · Clinical Cancer Research · 177

PDF

A Novel Proximity Assay for the Detection of Proteins and Protein Complexes: Quantitation of HER1 and HER2 Total Protein Expression and Homodimerization in Formalin-fixed, Paraffin-Embedded Cell Lines and Breast Cancer Tissue

2009 · Yining Shi, Weidong Huang, et al. · Diagnostic Molecular Pathology · 91

Temporal trend and attributable risk factors of cardiovascular disease burden for adults 55 years and older in 204 countries/territories from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021

2024 · Ming-si Wang, Jing-wen Deng, et al. · European Journal of Preventive Cardiology · 81

p95HER2–T cell bispecific antibody for breast cancer treatment

2018 · Irene Rius Ruiz, Rocio Vicario, et al. · Science Translational Medicine · 81

Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10

2019 · Jame Abraham, Albert J. Montero, et al. · Journal of Clinical Oncology · 78

In vitro Drug Response and Molecular Markers Associated with Drug Resistance in Malignant Gliomas

2006 · John P. Fruehauf, Henry Brem, et al. · Clinical Cancer Research · 78

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

2013 · Allan Lipton, Laurie Goodman, et al. · Breast Cancer Research and Treatment · 77

PDF

Estimating an EQ-5D-Y-3L Value Set for China

2022 · Zhihao Yang, Jie Jiang, et al. · PharmacoEconomics · 71

PDF

Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China

2018 · Weidong Huang, Jinjin Yang, et al. · BMJ Open · 69

PDF

Factors associated with the quality of life of family caregivers for leukemia patients in China

2017 · Hongjuan Yu, Limin Li, et al. · Health and Quality of Life Outcomes · 68

PDF

Immunohistochemical Analysis of Advanced Human Breast Carcinomas Reveals Downregulation of Protein Kinase Cα

2004 · Christopher Kerfoot, Weidong Huang, et al. · Journal of Histochemistry & Cytochemistry · 67

PDF

The red wine component ellagic acid induces autophagy and exhibits anti‐lung cancer activity in vitro and in vivo

2018 · Jing Duan, Ji‐Cheng Zhan, et al. · Journal of Cellular and Molecular Medicine · 65

PDF

Chemotherapy resistance and oncogene expression in non–small cell lung cancer

2007 · Thomas A. d‘Amato, Rodney J. Landreneau, et al. · Journal of Thoracic and Cardiovascular Surgery · 65

PDF

2021 · Erwei Zheng, Jiao Xu, et al. · Frontiers in Public Health · 64

PDF

Assessing Health-Related Quality of Life of Chinese Adults in Heilongjiang Using EQ-5D-3L

2017 · Weidong Huang, Hongjuan Yu, et al. · International Journal of Environmental Research and Public Health · 62

PDF

Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies

2015 · Netanya I. Pollock, Lin Wang, et al. · Clinical Cancer Research · 60

PDF

Economic Burden for Lung Cancer Survivors in Urban China

2017 · Xin Zhang, Shuai Liu, et al. · International Journal of Environmental Research and Public Health · 58

PDF

Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization‐positive patients with metastatic breast cancer treated with trastuzumab

2010 · Allan Lipton, Wolfgang J. Köstler, et al. · Cancer · 52

PDF

Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark®) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor Specimens

2010 · Jeffrey S. Larson, Laurie J. Goodman, et al. · Pathology Research International · 51

PDF

Measurement Properties of the EQ-5D-5L and EQ-5D-3L in Six Commonly Diagnosed Cancers

2020 · Xueyun Zeng, Mingjie Sui, et al. · Patient · 49

Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival

2015 · Denise A Yardley, Peter A Kaufman, et al. · Breast Cancer Research · 47

PDF

Comparison of Central HER2 Testing With Quantitative Total HER2 Expression and HER2 Homodimer Measurements Using a Novel Proximity-Based Assay

2010 · Weidong Huang, Monica Reinholz, et al. · American Journal of Clinical Pathology · 46

PDF

High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)

2018 · Saranya Chumsri, Jeff Sperinde, et al. · Clinical Cancer Research · 43

Prolonged Response to Trastuzumab in a Patient With HER2-Nonamplified Breast Cancer With Elevated HER2 Dimerization Harboring anERBB2S310F Mutation

2015 · Saranya Chumsri, Jodi Weidler, et al. · Journal of the National Comprehensive Cancer Network · 41

PDF

Quantitation of HER2 Expression or HER2:HER2 Dimers and Differential Survival in a Cohort of Metastatic Breast Cancer Patients Carefully Selected for Trastuzumab Treatment Primarily by FISH

2009 · Christine Desmedt, Jeff Sperinde, et al. · Diagnostic Molecular Pathology · 40

Works count: 95

Citation count: 2,203

H-index: 29

I10-index: 46